2 February 2017
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
Reckitt Benckiser Group plc
Statement regarding Mead Johnson
Reckitt Benckiser Group plc ("RB") notes the recent press speculation regarding a possible transaction involving Mead Johnson Nutrition Company ("Mead Johnson").
RB confirms that it is in advanced negotiations to acquire each Mead Johnson share for $90 in cash, valuing Mead Johnson's entire share capital at approximately $16.7 billion.
The parties are presently engaged in a period of due diligence and contract discussion.
RB presently expects to finance the possible transaction through a combination of cash and debt, whilst retaining a strong investment grade credit rating.
There is no certainty that any transaction will ultimately be agreed, nor as to the terms on which any transaction might occur.
A further announcement will be made as appropriate.
For further information, please contact:
|
RB Richard Joyce SVP, Investor Relations, Communications & External Affairs |
+44 (0)1753 217800 |
|
Brunswick (Financial PR) Gabrielle Silver & David Litterick |
+44 (0)20 7404 5959 |
This information is provided by RNS